Dapagliflozin Intermediate Sourcing: DAPA-I vs DAPA-II — Which Do You Need?
for Dapagliflozin Intermediate Sourcing – A practical guide to choosing between the
Rajat Sharma
- August 18, 2026
- Diabetes — Gliptins & SGLT2
- No Comments
Category: Diabetes — Gliptins & SGLT2
Vildagliptin Intermediate (CAS 207557-35-5) -Manufacturer Evaluation Checklist
What this vildagliptin intermediate is, where it fits in the synthesis route,
- August 18, 2026
- Diabetes — Gliptins & SGLT2
- No Comments
Why Diabetes API Demand Is Growing Fastest in South and Southeast Asia
Why Diabetes API Demand Is Growing- Rising prevalence, a growing population, and
- August 17, 2026
- Diabetes — Gliptins & SGLT2
- No Comments
How Acarbose Is Manufactured: Alpha-Glucosidase Inhibitor
How Acarbose Is Manufactured: Alpha-Glucosidase Inhibitor : Acarbose stands apart from most
- August 15, 2026
- Diabetes — Gliptins & SGLT2
- No Comments
Gliptin vs SGLT2 Inhibitors APIs — Demand Differences for Generic Manufacturers
A grounding overview of how demand dynamics, market maturity, and manufacturing complexity
- August 11, 2026
- Diabetes — Gliptins & SGLT2
- No Comments
What Is Dapagliflozin and How DAPA-1/DAPA-2 Intermediates Are Synthesized
An introductory guide to dapagliflozin’s mechanism of action and synthesis route —
- August 8, 2026
- Diabetes — Gliptins & SGLT2
- No Comments
DPP-4 Inhibitor -Gliptin Intermediates Explained: Vildagliptin, Saxagliptin, Linagliptin, Alogliptin
An introductory guide to the key synthesis intermediates behind four major DPP-4
- August 7, 2026
- Diabetes — Gliptins & SGLT2
- No Comments